A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients

Inclusion Criteria

• •Diabetes Mellitus, Type 2
• •Have been receiving metformin and at least one other oral antihyperglycemic medication (sulfonylurea or thiazolidinedione) with insulin for at least 3 months prior to Visit 1 (Screening)
• •Hemoglobin A1C (HbA1c) greater than or equal to 7.5% and less than or equal to 11.0%
• •Body Mass Index (BMI) greater than or equal to 25 and less than or equal to 45 kg/m\^2
• •Capable and willing to follow the protocol
• •Give written consent
• •Have a history of severe hypoglycemia in the past 6 months
• •Are pregnant or may become pregnant
• •Women who are breastfeeding
• •Have significant cardiac disease
• •Have significant renal or liver disease
• •Undergoing therapy for a malignancy
• •Contraindications to the study medications
• •Have an irregular sleep/wake cycle
• •Have a serious disease or any condition considered by the investigator to be exclusionary